Clinical trials

  • Oxygen for Postoperative desaturation (hypoxaemia) | Risk of postoperative complications after general surgery | Risk of postoperative complications after urological surgery
  • TELISOTUZUMAB ADIZUTECAN for Non-small cell lung cancer (non-squamous, advanced or metastatic)
  • TX000045 for Pulmonary hypertension | Heart failure with preserved ejection fraction (HFpEF)
  • MCLA-129 for Non-small cell lung cancer | Solid tumours
  • RILVEGOSTOMIG for Metastatic squamous non-small cell lung cancer (PD-L1 expressing)
  • AMG 193 for Non-small cell lung cancer | MTAP-deleted non-small cell lung cancer
  • POTASSIUM HYDROXIDE for Actinic keratosis
  • TRASTUZUMAB DERUXTECAN for HER2-positive early breast cancer
  • Ibrutinib for Mantle cell lymphoma
  • [14C] ABBV-932 for Healthy volunteers
  • IVOSIDENIB for Cholangiocarcinoma | Cholangiocarcinoma with IDH1 mutation
  • ZL-1310 for Small cell lung cancer